SPCs outlive patent protections in 91% of cases, new report reveals

24-06-2021

Muireann Bolger

SPCs outlive patent protections in 91% of cases, new report reveals

metamorworks / Shutterstock.com

Supplementary protection certificates (SPCs) outlive medicinal patents in more than nine in ten cases, a new report has found.


Life sciences, SPCs, filing patterns, patents, big pharma

LSIPR